4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-23-070014
Options or other derivatives
- Chief Medical Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kim Robert Young Chief Medical Officer | 2023-12-11 | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | D | ||
Loading xslF345X05/ownership.xml…